244 related articles for article (PubMed ID: 34951657)
41. Mody-3: novel HNF1A mutation and the utility of glucagon-like peptide (GLP)-1 receptor agonist therapy.
Docena MK; Faiman C; Stanley CM; Pantalone KM
Endocr Pract; 2014 Feb; 20(2):107-11. PubMed ID: 24014008
[TBL] [Abstract][Full Text] [Related]
42. Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a(-/-) Model.
Urbanova J; Andel M; Potockova J; Klima J; Macek J; Ptacek P; Mat'oska V; Kumstyrova T; Heneberg P
Curr Pharm Des; 2015; 21(39):5736-48. PubMed ID: 26446475
[TBL] [Abstract][Full Text] [Related]
43. Effects of hepatocyte nuclear factor-1A and -4A on pancreatic stone protein/regenerating protein and C-reactive protein gene expression: implications for maturity-onset diabetes of the young.
Kyithar MP; Bonner C; Bacon S; Kilbride SM; Schmid J; Graf R; Prehn JH; Byrne MM
J Transl Med; 2013 Jun; 11():156. PubMed ID: 23803251
[TBL] [Abstract][Full Text] [Related]
44. Homozygous Hypomorphic
Misra S; Hassanali N; Bennett AJ; Juszczak A; Caswell R; Colclough K; Valabhji J; Ellard S; Oliver NS; Gloyn AL
Diabetes Care; 2020 Apr; 43(4):909-912. PubMed ID: 32001615
[TBL] [Abstract][Full Text] [Related]
45. An alternative approach using hs-CRP levels and age of onset in diagnostics of HNF1A-MODY.
Kickova T; Skopkova M; Dobiasova Z; Lackova G; Belicova Z; Schenkova K; Stanik J; Gasperikova D
Diabet Med; 2024 May; 41(5):e15265. PubMed ID: 38093550
[TBL] [Abstract][Full Text] [Related]
46. Plasma Fucosylated Glycans and C-Reactive Protein as Biomarkers of HNF1A-MODY in Young Adult-Onset Nonautoimmune Diabetes.
Juszczak A; Pavić T; Vučković F; Bennett AJ; Shah N; Pape Medvidović E; Groves CJ; Šekerija M; Chandler K; Burrows C; Rojnić Putarek N; Vučić Lovrenčić M; Ćuća Knežević J; James TJ; Gloyn AL; Lauc G; McCarthy MI; Owen KR; Gornik O
Diabetes Care; 2019 Jan; 42(1):17-26. PubMed ID: 30455330
[TBL] [Abstract][Full Text] [Related]
47. The spectrum of HNF1A gene mutations in patients with MODY 3 phenotype and identification of three novel germline mutations in Turkish Population.
Karaca E; Onay H; Cetinkalp S; Aykut A; Göksen D; Ozen S; Atik T; Darcan S; Tekin IM; Ozkınay F
Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S491-S496. PubMed ID: 28395978
[TBL] [Abstract][Full Text] [Related]
48. Structure-function studies of HNF1A (MODY3) gene mutations in South Indian patients with monogenic diabetes.
Balamurugan K; Bjørkhaug L; Mahajan S; Kanthimathi S; Njølstad PR; Srinivasan N; Mohan V; Radha V
Clin Genet; 2016 Dec; 90(6):486-495. PubMed ID: 26853433
[TBL] [Abstract][Full Text] [Related]
49. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
[TBL] [Abstract][Full Text] [Related]
50. Lipoprotein composition in HNF1A-MODY: differentiating between HNF1A-MODY and type 2 diabetes.
McDonald TJ; McEneny J; Pearson ER; Thanabalasingham G; Szopa M; Shields BM; Ellard S; Owen KR; Malecki MT; Hattersley AT; Young IS
Clin Chim Acta; 2012 May; 413(9-10):927-32. PubMed ID: 22360925
[TBL] [Abstract][Full Text] [Related]
51. A case of digenic maturity onset diabetes of the young with heterozygous variants in both HNF1Α and HNF1Β genes.
Patouni K; Cinek O; Pruhova S; Elblova L; Xatzipsalti M; Sertedaki A; Vazeou A
Eur J Med Genet; 2021 Sep; 64(9):104264. PubMed ID: 34161864
[TBL] [Abstract][Full Text] [Related]
52. Reduced pancreatic volume in hepatocyte nuclear factor 1A-maturity-onset diabetes of the young.
Vesterhus M; Haldorsen IS; Raeder H; Molven A; Njølstad PR
J Clin Endocrinol Metab; 2008 Sep; 93(9):3505-9. PubMed ID: 18593771
[TBL] [Abstract][Full Text] [Related]
53. The Common
Locke JM; Saint-Martin C; Laver TW; Patel KA; Wood AR; Sharp SA; Ellard S; Bellanné-Chantelot C; Hattersley AT; Harries LW; Weedon MN
Diabetes; 2018 Sep; 67(9):1903-1907. PubMed ID: 29895593
[TBL] [Abstract][Full Text] [Related]
54. Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families.
Costa A; Bescós M; Velho G; Chêvre J; Vidal J; Sesmilo G; Bellanné-Chantelot C; Froguel P; Casamitjana R; Rivera-Fillat F; Gomis R; Conget I
Eur J Endocrinol; 2000 Apr; 142(4):380-6. PubMed ID: 10754480
[TBL] [Abstract][Full Text] [Related]
55. Clinical application of ACMG-AMP guidelines in HNF1A and GCK variants in a cohort of MODY families.
Santana LS; Caetano LA; Costa-Riquetto AD; Quedas EPS; Nery M; Collett-Solberg P; Boguszewski MCS; Vendramini MF; Crisostomo LG; Floh FO; Zarabia ZI; Kohara SK; Guastapaglia L; Passone CGB; Sewaybricker LE; Jorge AAL; Teles MG
Clin Genet; 2017 Oct; 92(4):388-396. PubMed ID: 28170077
[TBL] [Abstract][Full Text] [Related]
56. Intima-media thickness and endothelial dysfunction in GCK and HNF1A-MODY patients.
Szopa M; Osmenda G; Wilk G; Matejko B; Skupien J; Zapala B; Młynarski W; Guzik T; Malecki MT
Eur J Endocrinol; 2015 Mar; 172(3):277-83. PubMed ID: 25501962
[TBL] [Abstract][Full Text] [Related]
57. RD Lawrence lecture 2012: assessing aetiology in diabetes: how C-peptide, CRP and fucosylation came to the party!
Owen KR
Diabet Med; 2013 Mar; 30(3):260-6. PubMed ID: 23106207
[TBL] [Abstract][Full Text] [Related]
58. Primary hepatocellular adenoma due to biallelic HNF1A mutations and its co-occurrence with MODY 3: case-report and review of the literature.
Fu J; Wang T; Zhai X; Xiao X
Endocrine; 2020 Mar; 67(3):544-551. PubMed ID: 31754975
[TBL] [Abstract][Full Text] [Related]
59. Bone morphogenetic protein 3 controls insulin gene expression and is down-regulated in INS-1 cells inducibly expressing a hepatocyte nuclear factor 1A-maturity-onset diabetes of the young mutation.
Bonner C; Farrelly AM; Concannon CG; Dussmann H; Baquié M; Virard I; Wobser H; Kögel D; Wollheim CB; Rupnik M; Byrne MM; König HG; Prehn JH
J Biol Chem; 2011 Jul; 286(29):25719-28. PubMed ID: 21628466
[TBL] [Abstract][Full Text] [Related]
60. Altered cortisol metabolism in individuals with HNF1A-MODY.
Juszczak A; Gilligan LC; Hughes BA; Hassan-Smith ZK; McCarthy MI; Arlt W; Tomlinson JW; Owen KR
Clin Endocrinol (Oxf); 2020 Sep; 93(3):269-279. PubMed ID: 32395877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
